Inotek Pharmaceuticals has raisedÂ $19.3 million in a third round of financing. New investors included Hercules Technology Growth Capital, Meditor Capital Management, and Mitsubishi UFJ Capital. Inotek said the money will be used to support the first proof of efficacy data for three separate therapeutic programs. Inotek also plans on expanding its development team.
- see this releaseÂ from Inotek